Literature DB >> 16945980

Avian influenza virus exhibits rapid evolutionary dynamics.

Rubing Chen1, Edward C Holmes.   

Abstract

Influenza A viruses from wild aquatic birds, their natural reservoir species, are thought to have reached a form of stasis, characterized by low rates of evolutionary change. We tested this hypothesis by estimating rates of nucleotide substitution in a diverse array of avian influenza viruses (AIV) and allowing for rate variation among lineages. The rates observed were extremely high, at >10(-3) substitutions per site, per year, with little difference among wild and domestic host species or viral subtypes and were similar to those seen in mammalian influenza A viruses. Influenza A virus therefore exhibits rapid evolutionary dynamics across its host range, consistent with a high background mutation rate and rapid replication. Using the same approach, we also estimated that the common ancestors of the hemagglutinin and neuraminidase sequences of AIV arose within the last 3,000 years, with most intrasubtype diversity emerging within the last 100 years and suggestive of a continual selective turnover.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945980     DOI: 10.1093/molbev/msl102

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  101 in total

1.  Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011.

Authors:  E M Abdelwhab; Abdel-Satar Arafa; Jürgen Stech; Christian Grund; Olga Stech; Marcus Graeber-Gerberding; Martin Beer; Mohamed K Hassan; Mona M Aly; Timm C Harder; Hafez M Hafez
Journal:  Virus Genes       Date:  2012-06-05       Impact factor: 2.332

2.  Evolution and adaptation of hemagglutinin gene of human H5N1 influenza virus.

Authors:  Kaifa Wei; Yanfeng Chen; Juan Chen; Lingjuan Wu; Daoxin Xie
Journal:  Virus Genes       Date:  2012-06       Impact factor: 2.332

Review 3.  Influenza: the once and future pandemic.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Public Health Rep       Date:  2010-04       Impact factor: 2.792

4.  Reply to "Complexities of Estimating Evolutionary Rates in Viruses".

Authors:  Daniel Rejmanek; Parviez R Hosseini; Jonna A K Mazet; Peter Daszak; Tracey Goldstein
Journal:  J Virol       Date:  2016-01-28       Impact factor: 5.103

5.  Complexities of Estimating Evolutionary Rates in Viruses.

Authors:  Edward C Holmes
Journal:  J Virol       Date:  2016-01-28       Impact factor: 5.103

6.  Evolutionary Dynamics and Global Diversity of Influenza A Virus.

Authors:  Daniel Rejmanek; Parviez R Hosseini; Jonna A K Mazet; Peter Daszak; Tracey Goldstein
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

7.  Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

Authors:  Yongli Xiao; Jae-Keun Park; Stephanie Williams; Mitchell Ramuta; Adriana Cervantes-Medina; Tyler Bristol; Sarah Smith; Lindsay Czajkowski; Alison Han; John C Kash; Matthew J Memoli; Jeffery K Taubenberger
Journal:  Virology       Date:  2019-06-13       Impact factor: 3.616

8.  Codon volatility of hemagglutinin genes of H5N1 avian influenza viruses from different clades.

Authors:  Prasert Auewarakul; Sunisa Chatsurachai; Alita Kongchanagul; Pumaree Kanrai; Sikarin Upala; Prapat Suriyaphol; Pilaipan Puthavathana
Journal:  Virus Genes       Date:  2009-03-24       Impact factor: 2.332

9.  Evolutionary dynamics of multiple sublineages of H5N1 influenza viruses in Nigeria from 2006 to 2008.

Authors:  Alice Fusaro; Martha I Nelson; Tony Joannis; Luigi Bertolotti; Isabella Monne; Annalisa Salviato; Olufemi Olaleye; Ismaila Shittu; Lanre Sulaiman; Lami H Lombin; Ilaria Capua; Edward C Holmes; Giovanni Cattoli
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  Anomalies in the influenza virus genome database: new biology or laboratory errors?

Authors:  Michael Krasnitz; Arnold J Levine; Raul Rabadan
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.